Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.

Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I; HNRC Group.

J Int Neuropsychol Soc. 2004 Jan;10(1):1-14.

PMID:
14751002
2.

[Study of HIV-related neuropsychological impairment: a review of methodological aspects].

RodríIguez Alvarez M, Rodriguez Salgado D.

Actas Esp Psiquiatr. 2003 Mar-Apr;31(2):79-84. Review. Spanish.

PMID:
12677472
3.

[Influence of factors not related with HIV infection on neuropsychological performance of HIV-seropositive patients].

Vázquez-Justo E, Rodríguez-Alvarez M.

Rev Neurol. 2002 Sep 1-15;35(5):474-80. Review. Spanish.

4.

[Methodological problems in the evaluation of cognitive disorders associated with HIV].

Pereda M, Gómez del Barrio A, Ayuso Mateos JL.

Neurologia. 1999 Nov;14(9):452-8. Review. Spanish. No abstract available.

PMID:
10613019
5.
6.

[Influence of infection related factors on neuropsychological performance of HIV seropositive subjects].

Rodríguez Alvarez M, Vázquez-Justo E.

Neurologia. 2002 Jun-Jul;17(6):328-36. Review. Spanish.

PMID:
12084360
7.

Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neuroimmune Pharmacol. 2016 Sep;11(3):495-510. doi: 10.1007/s11481-016-9699-0. Epub 2016 Aug 2. Review.

8.

Do asymptomatic HIV-seropositive individuals show cognitive deficit?

Newman SP, Lunn S, Harrison MJ.

AIDS. 1995 Nov;9(11):1211-20. Review. No abstract available.

PMID:
8561973
9.

The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis.

Passaro RC, Pandhare J, Qian HZ, Dash C.

J Neuroimmune Pharmacol. 2015 Sep;10(3):477-86. doi: 10.1007/s11481-015-9604-2. Epub 2015 Apr 8. Review.

10.

Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV.

Moore RC, Fazeli PL, Jeste DV, Moore DJ, Grant I, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

AIDS Behav. 2014 Jun;18(6):1186-97. doi: 10.1007/s10461-014-0743-x. Review.

11.

HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads.

Borgmann K, Ghorpade A.

Front Microbiol. 2015 Oct 27;6:1143. doi: 10.3389/fmicb.2015.01143. eCollection 2015. Review.

12.

Management of methamphetamine abuse and dependence.

Ling W, Rawson R, Shoptaw S, Ling W.

Curr Psychiatry Rep. 2006 Oct;8(5):345-54. Review.

PMID:
16968614
13.

Impact of methamphetamine on infection and immunity.

Salamanca SA, Sorrentino EE, Nosanchuk JD, Martinez LR.

Front Neurosci. 2015 Jan 12;8:445. doi: 10.3389/fnins.2014.00445. eCollection 2014. Review.

Supplemental Content

Support Center